Dosage forms and regimens for amino acid compounds
US11419869B2 · kind B2 · utility
4Cited by
6References
72Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2020 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Apr 8, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.